Additionally, many studies have demonstrated that fatostatin, nelfinavir, AR antagonist, natural compounds, or herbal extracts can target SREBP-1 and its downstream targets for the inhibition of lipid biosynthesis in tumor growth and progression of various cancers. The gene discussed is AR; the disease is neoplasm.